If you want the shortest answer, it is this: Semaglutide is still a strong option
Nearly 70% of participants lost more than 10% of their body weight, and over 50% lost more than 15%
Its most often caused by viral infections
Tirzepatide demonstrated superior improvements across several upper-respiratory conditionsincluding rhinorrhea, nasal congestion, and earachewhere fold-reductions were consistently larger than those observed with semaglutide
Semaglutide is not approved specifically for PCOS, and individual treatment decisions are made by your physician
In individuals with diabetes who are diagnosed with heart or blood vessel problems, this medication is also used to reduce the risk of a heart attack, stroke, or death